NAIROBI, Kenya, Jan 05 (IPS) – The ANTICOV COVID-19 clinical trial, aimed at identifying treatments that prevent mild cases from progressing to severe forms of the disease, is crucial to Africa, researchers say. The trial will investigate home-based treatments to help prevent local health systems from being overwhelmed.
Read the full story, “ANTICOV Treatment Clinical Trial Crucial for Africa”, on globalissues.org →
